CME Group Q3 2026: record revenue, adjusted EPS of $3.02 matches consensus
CME delivered a record third quarter: revenue rose 13.0% to $1.7373 billion, and adjusted EPS of $3.02 matched the $3.0193 consensus almost exactly. The read-through is simple: more contracts traded at a slightly lower average price, plus record market data. Below: revenue quality, the cost puts and takes, and why there is no company guidance to grade.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS was $2.89 against $2.49 a year earlier, and adjusted EPS was $3.02 against $2.68. Versus a $3.0193 consensus, that is a rounding-distance match rather than a beat. Most of the GAAP-to-adjusted gap is $56.0 million of purchased-intangible amortization.
$1.7373 billion, up 13.0% from $1.5376 billion a year earlier and the highest third-quarter revenue on record — though still the second-highest quarter ever, behind Q1 2026's $1.8801 billion. Volume did the work: average daily volume was 29.4 million contracts versus 25.3 million a year ago. Market data added a record $243.1 million, up 20.0%.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-10-23
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.